HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Higher Safety Risk For Import Supplements Sold At 'Non-Traditional Places'

This article was originally published in The Tan Sheet

Executive Summary

FDA officials most every day find imports containing products labeled as dietary supplements but spiked with drug ingredients, or nonprescription drug products that are not compliant with US regulations. Immigrant consumers particularly are susceptible to using those products, FDA says.

You may also be interested in...



FDA Reaps More Spiked Supplements From International Mail Shipments

FDA identifies 14 products in examinations of international mail shipments found to contain approved and banned drug ingredients indicated for weight loss, erectile dysfunction and depression.

Methanol-Contaminated Sanitizers Stain Production Flexibility Spurred By Pandemic In US

In update to notifications about hand sanitizer labeled as containing ethyl alcohol but contaminated with methanol, FDA says some distributors are voluntarily recalling products. But manufacturer Eskbiochem didn't respond to request to recall its products marketed in US under multiple brands.

US FDA Wants To Improve Communication, Education On Supplements, Cosmetics

Supplement industry stakeholders say proposal could reveal helpful information about consumers’ regard for VMS products. But until the questions FDA will ask in interviews are known, it’s not clear whether the information collection might sow doubt about the products.

Topics

UsernamePublicRestriction

Register

ID1131437

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel